MYRIAD GENETICS, INC. Payments for (Proceeds from) Tenant Allowance
MYRIAD GENETICS, INC. (MYGN) reported Payments for (Proceeds from) Tenant Allowance of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromTenantAllowance · last filed 2026-02-24
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2024-12-31 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2024-09-30 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2024-06-30 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for the quarter ending 2024-03-31 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for fiscal 2025 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for fiscal 2024 was $0.00.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for fiscal 2023 was -$16.30M.
- MYRIAD GENETICS, INC. payments for (proceeds from) tenant allowance for fiscal 2022 was -$18.00M.
| Period end | Payments for (Proceeds from) Tenant Allowance 3 month | Payments for (Proceeds from) Tenant Allowance 6 month | Payments for (Proceeds from) Tenant Allowance 9 month | Payments for (Proceeds from) Tenant Allowance 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | -$3.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | -$3.10M derived: sum of 3 quarters · filed 2026-02-24 | -$16.30M 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$3.10M derived: sum of 2 quarters · filed 2024-11-08 | -$16.30M 10-Q · filed 2024-11-08 | -$25.70M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$16.30M 10-Q · filed 2024-08-07 | -$25.70M derived: sum of 3 quarters · filed 2025-02-28 | -$34.30M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$13.20M 10-Q · filed 2024-05-08 | -$22.60M derived: sum of 2 quarters · filed 2025-02-28 | -$31.20M derived: sum of 3 quarters · filed 2025-02-28 | -$31.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$18.00M derived: sum of 2 quarters · filed 2025-02-28 | -$18.00M derived: sum of 3 quarters · filed 2025-02-28 | -$18.00M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$8.60M derived: sum of 2 quarters · filed 2023-11-07 | -$8.60M 10-Q · filed 2023-11-07 | -$8.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-06-30 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |